Cardinal Health (CAH) Projected to Release Earnings on Thursday

Cardinal Health (NYSE:CAH) is projected to release its Q1 2027 results before the market opens on Thursday, November 5th. Analysts expect Cardinal Health to post earnings of $2.94 per share and revenue of $66.67 billion for the quarter. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Parties may visit the company’s upcoming Q1 2027 earnings results page for the latest details on the call scheduled for Thursday, November 5, 2026 at 8:30 AM ET.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The firm had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. During the same period last year, the company earned $2.08 EPS. The company’s quarterly revenue was up 5.8% on a year-over-year basis. On average, analysts expect Cardinal Health to post $12.55 EPS for the current fiscal year and $13.91 EPS for the next fiscal year.

Cardinal Health Price Performance

NYSE CAH opened at $254.69 on Tuesday. The firm’s 50-day moving average is $238.24 and its two-hundred day moving average is $222.52. Cardinal Health has a 12 month low of $180.45 and a 12 month high of $259.84. The stock has a market capitalization of $58.98 billion, a P/E ratio of 35.23, a PEG ratio of 1.47 and a beta of 0.50.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st were given a dividend of $0.5158 per share. The ex-dividend date was Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.8%. Cardinal Health’s dividend payout ratio (DPR) is currently 28.49%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the stock. Morgan Stanley boosted their price target on shares of Cardinal Health from $265.00 to $286.00 and gave the company an “overweight” rating in a research note on Friday. Wells Fargo & Company increased their price objective on shares of Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, October 25th. Barclays lifted their target price on shares of Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a report on Thursday, August 13th. Finally, Leerink Partners set a $292.00 target price on Cardinal Health in a research report on Tuesday, August 11th. Sixteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $270.69.

Insider Activity

In related news, insider Jessica Mayer sold 29,436 shares of the firm’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total transaction of $6,952,488.84. Following the completion of the transaction, the insider directly owned 33,076 shares in the company, valued at $7,812,220.44. This trade represents a 47.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Jason Hollar sold 80,000 shares of Cardinal Health stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $235.74, for a total value of $18,859,200.00. Following the completion of the transaction, the chief executive officer directly owned 235,132 shares of the company’s stock, valued at approximately $55,430,017.68. This represents a 25.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 210,271 shares of company stock worth $49,626,657 in the last quarter. Insiders own 0.12% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.